about
Prevention of epileptogenesis--a new goal for epilepsy therapyMolecular neurobiology of mTOREpilepsy in newborns with tuberous sclerosis complex."Drop attacks" as first clinical symptoms in a child carrying MTTK m.8344A>G mutation.Expression of Bcl-2 and Bax protein in normal pineal gland in children and young adult.Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex.A shower of second hit events as the cause of multifocal renal cell carcinoma in tuberous sclerosis complex.Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligaseSevere central and peripheral paraneoplastic demyelination associated with tumours of the ovaries.The role of melatonin in the neurodegenerative diseases.Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis.Tuberous sclerosis complex: advances in diagnosis, genetics, and management.Gene table: monogenic determined neurocutaneous disorders.Brain lesions in tuberous sclerosis complex. Review.Tuberous sclerosis complex: tumors and tumorigenesis.Dietary treatment of epilepsy: rebirth of an ancient treatment.Everolimus (RAD001): first systemic treatment for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.Role of mTOR inhibitors in epilepsy treatment.Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review.Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC.Management of side effects of mTOR inhibitors in tuberous sclerosis patients.The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions.Topical Use of Mammalian Target of Rapamycin (mTOR) Inhibitors in Tuberous Sclerosis Complex-A Comprehensive Review of the Literature.Tuberous sclerosis complex: From molecular biology to novel therapeutic approaches.Safety of Everolimus in Patients Younger than 3 Years of Age: Results from EXIST-1, a Randomized, Controlled Clinical Trial.Tuberin and hamartin expression is reduced in the majority of subependymal giant cell astrocytomas in tuberous sclerosis complex consistent with a two-hit model of pathogenesis.Melatonin secretion profile after experimental pineal gland compression in rats.Do peripheral nerve extracts protect retinal ganglion cells from axotomy-induced death?Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.Influence of nerve growth factor upon the injured peripheral nerve in the absence of its distal part.EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients.Fibroblasts from normal skin of a tuberous sclerosis patient show upregulation of mTOR pathway.Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling.Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.Report on the Round Table Conference on Medical Care Management of Patients with Neurocutaneous Syndromes.Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?The influence of trkB deficiency on long-term outcome of peripheral nerve injury in mice.BDNF contributes to animal model neuropathic pain after peripheral nerve transection.
P50
Q27015632-0FB7A316-C5FE-499F-852D-DBDF44CAFCFCQ28072706-0174B9F2-B42A-4117-9017-53D700C358ACQ30836801-CC51791E-4CD4-4D4B-945F-22AE99C260F3Q33163684-7EB03D1D-C13D-4DF3-8648-72333AD196BDQ33249561-ADCE6CF9-7599-4D0D-8DD1-62E2C15D789FQ33325859-71D1BFD4-333D-464B-9AA5-F02082F48569Q34468812-6C9C45CF-8232-4A7E-A928-67CC34A54E03Q35163442-5864D212-4111-4EF1-99CD-EE2B61E5B5F5Q35899265-3483EE71-9A4A-4805-8A85-A7ECF395257BQ36030037-F3AD3531-7C8F-49AF-BA8E-F108B61383D2Q36218443-14FFE05D-38BE-4332-A09B-9BE33F4345BDQ36545074-8C377CB4-F32A-486B-B43B-602F2B361FF0Q36595635-E2408311-E4D2-4C16-909E-FD2E549EE8F5Q36885294-1ED9ECAA-74D3-4C64-8BA8-BE4255107E9DQ37767940-A308A2D0-6439-4ADD-8BAE-77AD5D84B890Q37798226-130598F9-C808-4C0A-935B-F35BED9D1F1BQ37823642-79D3A24E-1BB7-43C4-8ED6-9492DC2A2E8AQ37958755-21C1A676-35F0-4D57-8811-DE73CB7BA90EQ38066584-4057AA7B-4324-4D48-A4D3-FF8C2665A8F3Q38453996-2BB75723-136E-4E9D-AF4F-97639F4D5DE6Q38592323-CC395FEF-B911-40AC-808D-9A6BC0E15D5FQ38694072-748F1FC5-5ABC-47C9-9C4D-761713254D5EQ38739340-1AD55F0F-00CC-4856-ADA4-4718A782C406Q38755497-78899D69-C31F-48F9-8144-E238D330973FQ38843710-C88B4C1A-9B79-4333-B038-95C8AEDC81C9Q38994919-6C0447DD-92E1-4984-88DB-49B15E87FBFCQ40012328-659CF802-B929-4473-8BB1-F14277AAFD5BQ44835748-C1ED161B-D4D1-4E89-90BF-76916A1181F4Q44837015-47ED4D68-E55A-4C96-9CFC-F267DA8E7033Q44851202-770BAB4F-9F2B-40AA-AE98-A30B11A4E904Q45205869-F7C39969-1864-4CA0-93E8-8A93E0B1E64DQ45270797-84044CF5-8CA0-448C-8887-18A286F87A61Q45965199-69B866E7-E494-4BE6-A5CF-F1A69E75A426Q46155858-5F54168B-8EF0-4BCB-9F65-C1A1E209D222Q46882899-67F132EB-FF69-4983-896A-00930EBDE405Q46908759-B1381A3D-B2C8-4A23-8C06-CA54BF0C37FAQ46941103-E0004C6F-20F4-4BC3-BB7F-E26364EFC34EQ47833968-0A462922-EDC2-407D-9070-4936234509A0Q48124960-7879D9B0-2FB8-4FC9-8F1C-AFFC545BC422Q48155384-95117DDF-CF6E-4F6B-8454-1141335341C7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Katarzyna Kotulska
@ast
Katarzyna Kotulska
@en
Katarzyna Kotulska
@es
Katarzyna Kotulska
@nl
Katarzyna Kotulska
@sl
type
label
Katarzyna Kotulska
@ast
Katarzyna Kotulska
@en
Katarzyna Kotulska
@es
Katarzyna Kotulska
@nl
Katarzyna Kotulska
@sl
altLabel
Katarzyna Kotulska-Jozwiak
@en
prefLabel
Katarzyna Kotulska
@ast
Katarzyna Kotulska
@en
Katarzyna Kotulska
@es
Katarzyna Kotulska
@nl
Katarzyna Kotulska
@sl
P106
P1153
53877756600
6603482231
P31
P496
0000-0002-5015-250X